<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Vestergaard | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/juteplain80/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/juteplain80/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Vestergaard.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">eade7ae1a232400c7f135cc7e537d43f</guid>
				<title>Vestergaard posted an update: Crucially, while many algae antiviral applications have [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41112/</link>
				<pubDate>Fri, 07 Feb 2025 11:24:05 -0800</pubDate>

									<content:encoded><![CDATA[<p>Crucially, while many algae antiviral applications have already reached successful commercialization, the large spectrum of algae antiviral capacities already identified suggests a strong potential for future expansion of this field.By observing the activity of anti-cancer agents directly in tumors, there is potential to greatly expand our&hellip;<span class="activity-read-more" id="activity-read-more-41112"><a href="http://www.nationalboardinstitute.com/activity/p/41112/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a315ad5aebba36784592f607147789e8</guid>
				<title>Vestergaard posted an update: 3D monolithic reactor has shown great promise for varied [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39299/</link>
				<pubDate>Wed, 05 Feb 2025 12:25:45 -0800</pubDate>

									<content:encoded><![CDATA[<p>3D monolithic reactor has shown great promise for varied heterogeneous catalysis reactions including water treatment, energy generation and storage, and clean fuel production. As a natural porous material, macroporous wood is regarded as an excellent support for inorganic catalyst due to its abundant polar functional groups and channels. On the&hellip;<span class="activity-read-more" id="activity-read-more-39299"><a href="http://www.nationalboardinstitute.com/activity/p/39299/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c97b9891d1aeeff7157adb3bcc760e6c</guid>
				<title>Vestergaard posted an update: Phytotochemical analysis indicates the key role of the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38662/</link>
				<pubDate>Tue, 04 Feb 2025 12:17:48 -0800</pubDate>

									<content:encoded><![CDATA[<p>Phytotochemical analysis indicates the key role of the triterpenoids in this process.A2B adenosine receptors are present in a wide spectrum of tissues, especially on cells of the immune system. Since these particular receptors have the lowest, of all adenosine receptor subtypes, affinity for adenosine they are believed to play a special role in&hellip;<span class="activity-read-more" id="activity-read-more-38662"><a href="http://www.nationalboardinstitute.com/activity/p/38662/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ea6a7bf4fcbe8fff28b941764cf818f8</guid>
				<title>Vestergaard posted an update: Portable autorefractors can estimate refractive error in [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36787/</link>
				<pubDate>Sun, 02 Feb 2025 11:57:48 -0800</pubDate>

									<content:encoded><![CDATA[<p>Portable autorefractors can estimate refractive error in remote locations, but sphero-cylinder comparison and donated-spectacle dispensing are not yet simple.</p>
<p> Normal astigmats determined best corrected acuity, then degraded 1 logMAR (Grade A), 3 logMAR (Grade B), and 6 logMAR (Grade C) to determine limits of astigmatism axis and power at&hellip;<span class="activity-read-more" id="activity-read-more-36787"><a href="http://www.nationalboardinstitute.com/activity/p/36787/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">36937316562c8e7507cdcc616fa384be</guid>
				<title>Vestergaard posted an update: 8-4.1%). Most cases were not serious (old formulation, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34123/</link>
				<pubDate>Thu, 30 Jan 2025 11:53:12 -0800</pubDate>

									<content:encoded><![CDATA[<p>8-4.1%). Most cases were not serious (old formulation, 65.8%; new formulation, 78.7%). Reporting rates were similar or higher for the old formulation within subgroups of at-risk patients. Nature/distributions of adverse events by thyroid-stimulating hormone levels as determined by both the marketing authorization holder of levothyroxine and the&hellip;<span class="activity-read-more" id="activity-read-more-34123"><a href="http://www.nationalboardinstitute.com/activity/p/34123/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">70bd5850a49e0edf360c06faeab01162</guid>
				<title>Vestergaard posted an update: Despite this initial decay, neutralizing activity at 6months [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31240/</link>
				<pubDate>Tue, 28 Jan 2025 16:33:53 -0800</pubDate>

									<content:encoded><![CDATA[<p>Despite this initial decay, neutralizing activity at 6months remained higher among hospitalized individuals compared to mild symptomatic. The slow decline in neutralizing activity at mid-term contrasted with the steep slope of anti-RBD, S2, or NP antibody titers, all of them showing a constant decline over the follow-up period.</p>
<p> Our results&hellip;<span class="activity-read-more" id="activity-read-more-31240"><a href="http://www.nationalboardinstitute.com/activity/p/31240/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">426e9761654a9fe68b5e731e1ec744a9</guid>
				<title>Vestergaard became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31235/</link>
				<pubDate>Tue, 28 Jan 2025 16:33:03 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>